A vaccine designed to protect humans against the H5N1 influenza virus, known as bird flu, has been approved for the first time in the United States.
The U.S. Food and Drug Administration announced the approval Tuesday. Officials said the vaccine could be used in the event of an influenza pandemic to provide early limited protection in the months before a vaccine tailored to a specific pandemic strain of the virus could be produced.
